Last Updated: 28 May 2020 12:02 PM

India Top Stories

 Times of India

  • India, Australia agree on Test series sans bio bubble with flexibility rider

    Cricket Australia and the BCCI have agreed against the need for a bio-secure environment for India's four-Test tour in December. TOI has learnt that CA assured BCCI the coronavirus was likely to be under control in Australia by year-end. The series will start in Brisbane on Dec 3, followed by day-night Test in Adelaide. The Boxing Day and New Year's Tests will be staged in Melbourne and Sydney.

  • Setback for Saina, Srikanth as BWF to retain Olympic points

    In a move that would dent the Olympic prospects of Saina Nehwal and Kidambi Srikanth, the Badminton World Federation has decided to maintain the points that players had already earned up to March 15, 2020 and consider them for the 2021 Olympic qualification. But this is good news for Sai Praneeth, Satwiksairaj Rankireddy and PV Sindhu, as they are within the range.

  • No decision yet on postponing T20 World Cup: ICC

    The International Cricket Council (ICC) has denied speculation that the T20 World Cup in Australia has been postponed to 2022, which might open up a window for the lucrative Indian Premier League (IPL) in October. The world governing body of the game, in fact, has categorically said that “preparations are ongoing for the event in Australia this year as per plan.”

  • IWLF nominates Khel Ratna recipient Mirabai Chanu for Arjuna award

    In an unusual move, ace lifter Mirabai Chanu has been nominated for the Arjuna award by the national federation through the former world champion is already a recipient of Khel Ratna, country's highest sporting honour. The Indian Weightlifting Federation (IWLF) has nominated Chanu along with Ragala Venkat Rahul and Punam Yadav. Chanu had received the Khel Ratna in 2018.

  • Wicketkeepers not getting consistent run to secure place in Indian team: Patel

    Veteran wicketkeeper-batsman Parthiv Patel feels India's young glovesmen should be given a "consistent run" to secure their place in the national team, something which has not been happening of late.

 Hindustan Times

 The Economic Times

 Lokmat Times


  • France halts hydroxychloroquine use for Covid-19 cases

    The French government on Wednesday banned treatment of Covid-19 patients with hydroxychloroquine, a controversial and potentially harmful drug that US Prez Trump has said he is taking preventively. The move came after two French advisory bodies and the WHO warned this week that the drug had been shown to be potentially dangerous in several studies.

  • As Trump offers to mediate between India and China, Beijing counsels restraint

    US President Donald Trump on Wednesday offered to "mediate" the border dispute between India and China, saying he was "ready, willing and able" to ease the tensions, amid the standoff between the armies of the two countries. Trump's offer, dismissed or ignored in China and India, surprised most observers given its timing – coming when Washington’s ties with Beijing are fraught.

  • Hong Kong police stamp out national anthem law protests

  • Time to move on, urges British PM Boris Johnson over Cummings row

    PM Boris Johnson said on Wednesday it was time for Britain to move on from what he described as a "very, very frustrating episode" when his closest adviser Dominic Cummings was accused of violating the coronavirus lockdown rules. "(If) what we need to do is to focus on getting the message right ... then I think what we need to do really is to move on," he said.

  • China has made great progress in Covid-19 vaccine research: Chinese Ambassador

    Chinese Ambassador to India Sun Weidong on Wednesday said that China has made "great progress" in vaccine research and development in the fight against Covid-19 and, when developed, it would be accessible to developing countries. He said China and India should join hands to strengthen cooperation against the epidemic, noting Indian govt's measures to contain the spread.

 Live Mint























 Times Bull